Evidence map›Paper›PMID 38248383›Full record

ArticleBiosensors2023

Faradaic Impedimetric Immunosensor for Label-Free Point-of-Care Detection of COVID-19 Antibodies Using Gold-Interdigitated Electrode Array.

Lian C T Shoute, Carmen L Charlton, Jamil N Kanji, Shawn Babiuk, Lorne Babiuk, Jie Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biosensors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lian C T ShouteDepartment of Electrical and Computer Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada.
Carmen L CharltonDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 1C9, Canada.
Jamil N KanjiDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 1C9, Canada.
Shawn BabiukNational Centre for Foreign Animal Disease, Canadian Food Inspection Agency, Winnipeg, MB R3E 3M4, Canada.ORCID 0000-0003-1265-7264
Lorne BabiukVaccine and Infectious Disease Organization, University of Alberta, Edmonton, AB T6G 2G3, Canada.
Jie ChenDepartment of Electrical and Computer Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada.ORCID 0000-0001-7925-3729
University of Alberta · CACanadian Food Inspection Agency · CA

Funding

Alberta Innovates and MITACS not applicable
6 · The paper itself

Abstract

Label-free electrochemical biosensors have many desirable characteristics in terms of miniaturization, scalability, digitization, and other attributes associated with point-of-care (POC) applications. In the era of COVID-19 and pandemic preparedness, further development of such biosensors will be immensely beneficial for rapid testing and disease management. Label-free electrochemical biosensors often employ [Fe(CN)

Indexed as

Biosensing TechniquesCOVID-19Spike Glycoprotein, CoronavirusAntibodies, Monoclonal, HumanizedElectrodesGoldHumansImmunoassayPoint-of-Care SystemsSARS-CoV-2Antibodies, Monoclonal, HumanizedGoldSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2baseline driftCOVID-19 antibody detectionFaradaic detectioninterdigitated electrode microelectrode arraylabel-freepinholes

Identifiers

PMID38248383
PMCPMC10812953
OpenAlexW4390114689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.